• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

感染性心内膜炎的流行病学、临床特征及转归趋势:韩国一项为期16年的全国性队列研究

Trends in Epidemiology, Clinical Characteristics, and Outcomes of Infective Endocarditis: A 16-Year Nationwide Cohort Study in Korea.

作者信息

Ha Kyung Eun, Kim William D, Ko Kyu-Yong, Kim Hasung, Gwak Seo-Yeon, Kim Kyu, Lee Hyun-Jung, Shim Chi Young, Hong Geu-Ru, Ha Jong-Won, Hwang Ji-Won, Cho Iksung

机构信息

Division of Cardiology, Department of Internal Medicine, Gachon University College of Medicine, Incheon, Korea.

Chung-Ang University College of Medicine, Seoul, Korea.

出版信息

J Korean Med Sci. 2025 Aug 11;40(31):e183. doi: 10.3346/jkms.2025.40.e183.

DOI:10.3346/jkms.2025.40.e183
PMID:40795340
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12339901/
Abstract

BACKGROUND

Infective endocarditis (IE) is a life-threatening disease, the profile of which varies across countries. This nationwide cohort study aimed to assess the epidemiology, clinical characteristics, and outcomes of IE.

METHODS

Patients diagnosed with IE between 2003 and 2018 were included in this study based on data from the National Health Insurance System of South Korea. The patients' baseline characteristics, treatment modalities, and survival outcomes were analyzed. The incidence and in-hospital mortality rates were calculated and adjusted for age.

RESULTS

A total of 8,487 IE cases were included: 6,617 (78.0%), 1,678 (19.8%), and 192 (2.3%) cases of native valve IE, prosthetic valve IE, and cardiac device-related IE (CDRIE), respectively. The incidence rate (per 1,000,000) of IE increased from 7.24 in 2003 to 17.47 in 2018. Furthermore, the in-hospital mortality rate for IE (per 1,000,000 person-years) increased from 0.59 in 2003 to 2.76 in 2018. The proportions of prosthetic valve IE and CDRIE cases increased over time, whereas that of native valve IE cases decreased. The number of surgeries for IE showed a consistent upward trend, with a notable increase occurring from 2014 onward.

CONCLUSION

IE is a health burden with an increasing incidence and high mortality rates. Understanding the epidemiology and characteristics of IE is crucial to establish future treatment strategies.

摘要

背景

感染性心内膜炎(IE)是一种危及生命的疾病,其特征在不同国家有所不同。这项全国性队列研究旨在评估IE的流行病学、临床特征和结局。

方法

基于韩国国民健康保险系统的数据,纳入2003年至2018年间诊断为IE的患者。分析患者的基线特征、治疗方式和生存结局。计算发病率和住院死亡率,并对年龄进行调整。

结果

共纳入8487例IE病例:分别为6617例(78.0%)原发性瓣膜心内膜炎、1678例(19.8%)人工瓣膜心内膜炎和192例(2.3%)心脏装置相关感染性心内膜炎(CDRIE)。IE的发病率(每100万人)从2003年的7.24增加到2018年的17.47。此外,IE的住院死亡率(每100万人年)从2003年的0.59增加到2018年的2.76。人工瓣膜心内膜炎和CDRIE病例的比例随时间增加,而原发性瓣膜心内膜炎病例的比例下降。IE手术数量呈持续上升趋势,从2014年起显著增加。

结论

IE是一种健康负担,发病率不断上升且死亡率高。了解IE的流行病学和特征对于制定未来治疗策略至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a71/12339901/6d22fe7da059/jkms-40-e183-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a71/12339901/9d64aed56bb5/jkms-40-e183-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a71/12339901/74b3106f828a/jkms-40-e183-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a71/12339901/9383e3dc38d7/jkms-40-e183-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a71/12339901/6d22fe7da059/jkms-40-e183-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a71/12339901/9d64aed56bb5/jkms-40-e183-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a71/12339901/74b3106f828a/jkms-40-e183-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a71/12339901/9383e3dc38d7/jkms-40-e183-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a71/12339901/6d22fe7da059/jkms-40-e183-g004.jpg

相似文献

1
Trends in Epidemiology, Clinical Characteristics, and Outcomes of Infective Endocarditis: A 16-Year Nationwide Cohort Study in Korea.感染性心内膜炎的流行病学、临床特征及转归趋势:韩国一项为期16年的全国性队列研究
J Korean Med Sci. 2025 Aug 11;40(31):e183. doi: 10.3346/jkms.2025.40.e183.
2
Incidence and disability-adjusted life-years of infective endocarditis in China from 1990 to 2021: comparison with G20 based on the Global Burden of Disease Study 2021.1990年至2021年中国感染性心内膜炎的发病率和伤残调整生命年:基于《2021年全球疾病负担研究》与二十国集团的比较
BMJ Open. 2025 Jul 6;15(7):e094490. doi: 10.1136/bmjopen-2024-094490.
3
Global and regional burden of infective endocarditis, 1990-2010: a systematic review of the literature.1990 - 2010年感染性心内膜炎的全球和地区负担:文献系统评价
Glob Heart. 2014 Mar;9(1):131-43. doi: 10.1016/j.gheart.2014.01.002.
4
A Systematic Review of Infective Endocarditis in Patients With Bovine Jugular Vein Valves Compared With Other Valve Types.牛颈静脉瓣与其他瓣型感染性心内膜炎患者的系统评价
JACC Cardiovasc Interv. 2017 Jul 24;10(14):1449-1458. doi: 10.1016/j.jcin.2017.04.025.
5
Epidemiology of community acquired and health care assocİated infective endocarditis and 28 day mortality risk factors: a university hospital study.社区获得性和医疗保健相关感染性心内膜炎的流行病学及28天死亡风险因素:一项大学医院研究。
BMC Infect Dis. 2025 Jul 31;25(1):968. doi: 10.1186/s12879-025-11386-4.
6
Optimal timing for early surgery in infective endocarditis: a meta-analysis.感染性心内膜炎早期手术的最佳时机:一项荟萃分析。
Interact Cardiovasc Thorac Surg. 2016 Mar;22(3):336-45. doi: 10.1093/icvts/ivv368. Epub 2015 Dec 17.
7
Infective endocarditis outcomes at a tertiary hospital in Western Australia: a retrospective cohort study from 2016 to 2021.西澳大利亚一家三级医院的感染性心内膜炎治疗结果:一项2016年至2021年的回顾性队列研究。
Intern Med J. 2024 Dec;54(12):2027-2036. doi: 10.1111/imj.16508. Epub 2024 Aug 28.
8
Hospitalizations for Infective Endocarditis in Children: 15-Year Analysis.儿童感染性心内膜炎的住院情况:15年分析
Acta Med Port. 2025 Jun 2;38(6-7):377-384. doi: 10.20344/amp.22196.
9
Infective endocarditis: a growing threat despite medical progress. A look at trends in Spain.感染性心内膜炎:尽管医学取得进步,但仍是日益严重的威胁。西班牙的趋势观察。
Rev Esp Cardiol (Engl Ed). 2025 Aug;78(8):717-723. doi: 10.1016/j.rec.2025.01.006. Epub 2025 Jan 25.
10
Aetiology, clinical characteristics, and risk factors influencing mortality in patients with infective endocarditis: a retrospective study.感染性心内膜炎患者的病因、临床特征及影响死亡率的危险因素:一项回顾性研究
Acta Cardiol. 2025 Aug;80(6):623-630. doi: 10.1080/00015385.2025.2511519. Epub 2025 Jun 3.

本文引用的文献

1
The Surgical Treatment of Infective Endocarditis: A Comprehensive Review.感染性心内膜炎的外科治疗:综述
Diagnostics (Basel). 2024 Feb 20;14(5):464. doi: 10.3390/diagnostics14050464.
2
2023 ESC Guidelines for the management of endocarditis.2023年欧洲心脏病学会感染性心内膜炎管理指南。
Eur Heart J. 2023 Oct 14;44(39):3948-4042. doi: 10.1093/eurheartj/ehad193.
3
The Assessment of Antimicrobial Resistance in Gram-Negative and Gram-Positive Infective Endocarditis: A Multicentric Retrospective Analysis.革兰氏阴性和革兰氏阳性感染性心内膜炎的抗菌药物耐药评估:一项多中心回顾性分析。
Medicina (Kaunas). 2023 Feb 24;59(3):457. doi: 10.3390/medicina59030457.
4
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2020.韩国癌症统计数据:2020 年发病率、死亡率、生存率和患病率。
Cancer Res Treat. 2023 Apr;55(2):385-399. doi: 10.4143/crt.2023.447.
5
Temporal association between invasive procedures and infective endocarditis.有创操作与感染性心内膜炎之间的时间关联。
Heart. 2023 Jan 11;109(3):223-231. doi: 10.1136/heartjnl-2022-321519.
6
Temporal trends and patterns of infective endocarditis in a Chinese population: A territory-wide study in Hong Kong (2002-2019).中国人群感染性心内膜炎的时间趋势和模式:香港地区的全区域研究(2002 - 2019年)
Lancet Reg Health West Pac. 2022 Mar 4;22:100417. doi: 10.1016/j.lanwpc.2022.100417. eCollection 2022 May.
7
Clinical, Microbiological, and Imaging Characteristics of Infective Endocarditis in Latin America: A Systematic Review.拉丁美洲感染性心内膜炎的临床、微生物学和影像学特征:系统评价。
Int J Infect Dis. 2022 Apr;117:312-321. doi: 10.1016/j.ijid.2022.02.022. Epub 2022 Feb 15.
8
Escalating incidence of infective endocarditis in Europe in the 21st century.21 世纪欧洲感染性心内膜炎发病率不断上升。
Open Heart. 2021 Oct;8(2). doi: 10.1136/openhrt-2021-001846.
9
Epidemiology of cardiovascular disease and its risk factors in Korea.韩国心血管疾病及其危险因素的流行病学
Glob Health Med. 2021 Jun 30;3(3):134-141. doi: 10.35772/ghm.2021.01008.
10
Geriatrics Fact Sheet in Korea 2021.《2021年韩国老年医学概况》
Ann Geriatr Med Res. 2021 Jun;25(2):65-71. doi: 10.4235/agmr.21.0063. Epub 2021 Jun 29.